Conditions: Acne Vulgaris
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 171
Healthy volunteers: no

Brief summary:
A 12-week evaluation of the safety and efficacy of dapsone gel 5% when used with tazarotene cream 0.1% compared with tazarotene cream 0.1% monotherapy in treating moderate to severe facial acne vulgaris

Detailed description:

Arms:
arm 1: Dapsone Gel 5% and Tazarotene Cream 0.1% arm 2: Tazarotene Cream 0.1%

Interventions: intervention 1: Dapsone intervention 2: Tazarotene
Intervention descriptions: intervention 1: Dapsone topical gel 5%, 1 pea-size amount BID x 12 weeks and Tazarotene Cream 0.1%, 1 pea-size amount QD x 12 weeks intervention 2: Tazarotene Cream 0.1%, 1 pea-size amount QD x 12 weeks

Protocol document: